71334-215 : Pyrukynd 50 mg Oral Tablet, Film Coated
| NDC: | 71334-215 |
| Labeler: | Agios Pharmaceuticals, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Pyrukynd |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | NDA216196 |
| Rev. Date: |
NDC Package Codes:
- 71334-215-50: 4 BLISTER PACK IN 1 CARTON (71334‑215‑50) > 14 TABLET, FILM COATED IN 1 BLISTER PACK (71334‑215‑14)
Active Ingredients:
- Mitapivat
Dosage Strength:
- 50 mg
Pharmaceutical Classes:
- Cytochrome P450 2B6 Inducers [MoA]
- Cytochrome P450 2C19 Inducers [MoA]
- Cytochrome P450 2C8 Inducers [MoA]
- Cytochrome P450 2C9 Inducers [MoA]
- Cytochrome P450 3A Inducers [MoA]
- P-Glycoprotein Inhibitors [MoA]
- Pyruvate Kinase Activator [EPC]
- Pyruvate Kinase Activators [MoA]
- UGT1A1 Inducers [MoA]
Related Products:
Based on records with the same trade name.- 71334-205 Pyrukynd 5 mg Oral Tablet, Film Coated by Agios Pharmaceuticals, Inc.
- 71334-210 Pyrukynd 20 mg Oral Tablet, Film Coated by Agios Pharmaceuticals, Inc.
- 71334-220 Pyrukynd 5 mg Oral Tablet, Film Coated by Agios Pharmaceuticals, Inc.
- 71334-225 PyrukyndPyrukynd Kit by Agios Pharmaceuticals, Inc.
- 71334-230 PyrukyndPyrukynd Kit by Agios Pharmaceuticals, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 71334-210Next: 71334-220 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.